Aimmune Therapeutics Prices IPO At $16.00/shr

(RTTNews) - Aimmune Therapeutics, Inc. announced the pricing of its initial public offering of 10 million shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions.

In addition, Aimmune has granted the underwriters a 30-day option to purchase up to an additional 1.50 million shares of common stock at the same price. Aimmune's common stock is expected to begin trading on The NASDAQ Global Select Market on August 6, 2015 under the symbol AIMT.

The offering is expected to close on August 11, 2015, subject to satisfaction of customary closing conditions.

BofA Merrill Lynch, Credit Suisse and Piper Jaffray are acting as joint book-running managers for the offering.